Gupta, S., & Gente, K. (2022). Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. Kidney international, 102(4), . https://doi.org/10.1016/j.kint.2022.07.019
Chicago Style (17th ed.) CitationGupta, Shruti, and Karolina Gente. "Acute Kidney Injury in Patients Receiving Pembrolizumab Combination Therapy Versus Pembrolizumab Monotherapy for Advanced Lung Cancer." Kidney International 102, no. 4 (2022). https://doi.org/10.1016/j.kint.2022.07.019.
MLA (9th ed.) CitationGupta, Shruti, and Karolina Gente. "Acute Kidney Injury in Patients Receiving Pembrolizumab Combination Therapy Versus Pembrolizumab Monotherapy for Advanced Lung Cancer." Kidney International, vol. 102, no. 4, 2022, https://doi.org/10.1016/j.kint.2022.07.019.